Coverage
-
October 17, 2022
Lawyers representing a group of Evolent Health Inc. Investors are asking a federal judge to approve a nearly $7.75 million fee award to settle a suit over whether the health care administration company harmed shareholders by purchasing one of its biggest clients, a Kentucky Medicaid plan, and nearly bankrupting it.
1 other articles on this case.
View all »